TELA Bio (TELA) Current Assets (2018 - 2026)

TELA Bio has reported Current Assets for 9 years, with the latest figure at $64.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 7.8% year-over-year to $64.3 million; the trailing twelve-month figure through Mar 2026 stood at $64.3 million (down 7.8% YoY), and the FY2025 full-year result was $75.6 million, down 3.19% from the prior year.
• Current Assets for Q1 2026 stood at $64.3 million, down from $75.6 million in the prior quarter.
• The five-year high for Current Assets was $89.2 million in Q2 2023, with the low at $44.1 million in Q3 2024.
• Average Current Assets over 5 years is $64.2 million, with a median of $62.6 million recorded in 2024.
• Year-over-year, Current Assets surged 95.4% in 2023 and sank 46.35% in 2024.
• Tracing TELA's Current Assets over 5 years: stood at $62.4 million in 2022, then grew by 14.86% to $71.7 million in 2023, then increased by 8.85% to $78.1 million in 2024, then dropped by 3.19% to $75.6 million in 2025, then declined by 14.92% to $64.3 million in 2026.
• The last three Current Assets figures came in at $64.3 million (Q1 2026), $75.6 million (Q4 2025), and $56.0 million (Q3 2025), per Business Quant data.

Peer Comparison